✉news HealthMedicine first seen 2 d ago, last 1 d ago, peak #37
Patient Death in BMS MS CAR-T Trial Unexplained
Original: A Patient Died in BMS’s MS CAR-T Trial. No One Can Say Why.
A patient has died during Bristol Myers Squibb's clinical trial of CAR-T cell therapy for multiple sclerosis, and the cause of death has not been disclosed or determined. The news raises safety questions about the experimental treatment, which reprograms immune cells. Observers are closely watching for further details from the company and regulators.
Why now: Unexplained deaths in experimental cell therapy trials draw immediate scrutiny over drug safety.
Bristol Myers SquibbCAR-T therapymultiple sclerosis
Rank over time, top of the chart is #1. 7 snapshots from 2 d ago to 1 d ago.
Evidence
- A Patient Died in BMS’s MS CAR-T Trial. No One Can Say Why. · The Clinical Trial Vanguard
API: https://socialmediatrends-api.osmike.com/v1/trends/3865718